bismuth subsalicylate (Pepto-Bismol) Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Bismuth subsalicylate, sold generically as pink bismuth and under the brand names Pepto-Bismol and BisBacter, is an antacid medication used to treat temporary discomforts of the stomach and gastrointestinal tract, such as nausea, heartburn, indigestion, upset stomach, and diarrhea.   Wikipedia

Chemistry

More Chemistry

Pharmacology

Drug Pricing (per unit)

United States

$0.0397 - $0.3321
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Alternative names

2-hydroxy-benzo[1,3,2]dioxabismin-4-one | basic bismuth salicylate | bismogenol | bismukote | bismuth oxide salicylate | bismuth oxysalicylate | bismuth subsalicylate | corrective suspension | gastro-cote | helidac | kaopectate | pepto-bismol | pink bismuth | subsalicylate bismuth | trigastronol | wismutsubsalicylat

Organizations (15)

Research & Development (13)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (8)

Approved Indications (2)


 

Diarrhea (approved 1939)

Helicobacter pylori (approved 1996)

Experimental Indications - Clinical Trial Phases 1-4 (8)


 

Bacterial Infections (Phase 4)

Breast Neoplasms (Phase 2)

Clostridium Infections (Phase 4)

Diarrhea (Phase 3)

Healthy Volunteers (Phase 1)

Helicobacter pylori (Phase 4)

Lymphoma (Phase 2)

Obesity, Morbid (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial Organizations: 13

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue